… described two homozygous deletions and one frame-shift mutation in prostate cancer cell
lines. More recently, PTEN mutations and dele tions were reported in metastatic prostate …

… for clinically relevant prostate cancer are needed. … prostate cancer cell lines of differing
origin [PC3 (bone metastasis), LNCaP (lymph node metastasis), and 22Rv1 (localized to prostate)…

… the low metastatic in vitro cell lines to determine if a discriminatory parameter could be … of
the particular prostatic cancer cell line. While the combination of the in vitro cell lines and their …

… prostate cancer cell line [11] stimulated with synthetic androgen because it represents a
well studied experimental resource and is a significant model for the study of prostate cancer. …

… utilized human prostate carcinoma cell lines including LNCaP and PC-3 cells as model
systems to investigate the role of AR expression in the androgen-stimulatory effect on cell growth…

… appeared slightly higher in the normal prostate epithelial cell line. However, only the L7a …
than in the hyperplastic prostate tissue. The only prostatecancer cell line whose transcript level …

… MDR-associated proteins in prostate cancer cell lines derived from … Furthermore, we measured
the response of the cell lines to … been used to challenge prostate cancer in clinical trials. …

… that curcumin also significantly inhibits the growth of prostate cancer cells in vivo (32) and in
… and independent (DU-145) prostate cancer cell lines is correlated with the repression of anti-…

… in studying the genetics of prostate cancer is shortage of commonly available in vitro prostate
cancer cell lines. There are only three commercially available cell lines: LNCaP, DU145, …